PHARMACOLOGY OF INTRAPERITONEAL CHEMOTHERAPY

被引:76
作者
MYERS, CE [1 ]
COLLINS, JM [1 ]
机构
[1] NCI, DIV RES SERV, BETHESDA, MD 20205 USA
关键词
D O I
10.3109/07357908309048508
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:395 / 407
页数:13
相关论文
共 59 条
  • [1] ADAMS GE, 1981, CANCER, V48, P696, DOI 10.1002/1097-0142(19810801)48:3<696::AID-CNCR2820480307>3.0.CO
  • [2] 2-V
  • [3] Babb A L, 1973, Proc Eur Dial Transplant Assoc, V10, P247
  • [4] BERGERAT JP, 1981, CANCER RES, V41, P25
  • [6] PROGNOSIS AND TREATMENT OF ENDOMETRIAL CANCER
    BERMAN, ML
    BALLON, SC
    LAGASSE, LD
    WATRING, WG
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1980, 136 (05) : 679 - 688
  • [7] THRESHOLD METHOTREXATE CONCENTRATION FOR IN-VIVO INHIBITION OF DNA-SYNTHESIS IN NORMAL AND TUMOROUS TARGET TISSUES
    CHABNER, BA
    YOUNG, RC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (08) : 1804 - 1811
  • [8] CLARKSON B, 1964, CLIN PHARMACOL THER, V5, P581
  • [9] CLEMENT JJ, 1980, CANCER RES, V40, P4165
  • [10] NON-LINEAR PHARMACOKINETIC MODELS FOR 5-FLUOROURACIL IN MAN - INTRAVENOUS AND INTRAPERITONEAL ROUTES
    COLLINS, JM
    DEDRICK, RL
    KING, FG
    SPEYER, JL
    MYERS, CE
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) : 235 - 246